Sequana Medical NV (EBR:SEQUA)
Belgium · Delayed Price · Currency is EUR 0.6110
0.00 (0.00%)
Apr 28, 2026, 5:35 PM CET
Sequana Medical NV Revenue
In the year 2024, Sequana Medical NV had annual revenue of 105.50K EUR, down -85.19%.
Revenue
105.50K
Revenue Growth
-85.19%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
43.56M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 105.50K | -606.67K | -85.19% |
| Dec 31, 2023 | 712.17K | -210.51K | -22.82% |
| Dec 31, 2022 | 922.69K | 552.19K | 149.04% |
| Dec 31, 2021 | 370.50K | -592.78K | -61.54% |
| Dec 31, 2020 | 963.28K | -7.36K | -0.76% |
| Dec 31, 2019 | 970.64K | -58.53K | -5.69% |
| Dec 31, 2018 | 1.03M | -274.81K | -21.07% |
| Dec 31, 2017 | 1.30M | -184.82K | -12.41% |
| Dec 31, 2016 | 1.49M | -196.12K | -11.64% |
| Dec 31, 2015 | 1.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 4.11B |
| Fagron NV | 952.17M |
| Ion Beam Applications | 620.18M |
| European Medical Solutions | 52.80M |
| Nyxoah | 15.33M |
| Hyloris Pharmaceuticals | 7.94M |
| Onward Medical | 5.41M |